Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
New York, NY and Mainz, Germany, February 1, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq:...
Year: 2021
Nova Leap Health Corp. to Force Conversion of 8% Convertible Debentures due December 30, 2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Feb. 01, 2021...
Zosano Pharma Presents Early-Onset of Action Data for Qtrypta™ in Acute Treatment of Migraines
Review of data from the ZOTRIP trial suggest that Qtrypta showed therapeutic gain at 30 minutes consistent with recently published...
Vaxil Appoints a Special Advisor to the Board of Directors
FURTHER UPDATE ON USAMRIID CHALLENGE AND ADDITIONAL EUROPEAN PATENT GRANTED FOR VAXIL’S ANTICANCER ANTIBODY PLATFORM Not for distribution by US...
Vystar Issues Corporate Update on Strategic Initiatives and the Impact of COVID-19 on Brands
RxAir 400 RxAir 400 UV-C light air purifiers destroy more than 99.9% of airborne viruses and bacteria, and are ideal...
Novan Completes Enrollment in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
– Topline data on track for targeted readout before the end of Q2 2021 – – SB206, if approved, has...
Better Choice Company Announces Ryan Wilson Vice President of Marketing
Pet Industry Veteran Brings Track Record of SuccessNEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR)...
Dyve Biosciences Appoints Camilla V. Simpson to Board of Directors
THOUSAND OAKS, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Dyve Biosciences, Inc. (“Dyve”), a clinical stage biotechnology company, today announced that...
Spectral Medical Appoints Dr. John Kellum as Chief Medical Officer
A World Authority in Blood Purification and Renal Replacement TherapyTORONTO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral”...
Cognition Therapeutics Publishes Evidence Identifying Receptor Integral in Parkinson’s Disease Pathology
PITTSBURGH, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative...
Cryometrix Rapid Deployment Low-Temperature Chest Freezer for Vaccines
OREM, Utah, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Merus to Participate in Upcoming Investor Conferences
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company...
Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions of the SARS-CoV-2 Spike Protein in the Development of Therapeutics
– Scientists continuing to advance critical research on mechanisms of immune evasion exemplified by emerging SARS-CoV-2 variants – – Study...
VYNE Therapeutics Announces FDA Approval of AMZEEQ® (Minocycline) Label Update
AMZEEQ® label update includes new information indicating the low propensity of Propionibacterium acnes (more commonly known as “P. acnes”) to...
CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 01, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating...
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., Feb. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA)...
Nemaura Medical Appoints Jay L. Warner as Head of U.S. Commercial Operations
LOUGHBOROUGH, England, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...
Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 Antibody, Toripalimab, in U.S. and Canada
Junshi Biosciences to receive up to an aggregate of US$1.11 billion of upfront payment, exercise fee and milestone payments from...
Zosano Pharma Announces NDA Resubmission Plans Following Type A Meeting with FDA
FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company...
AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection
Continues to Innovate and Build Strong IP PortfolioSAN JOSE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co.,...